Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

Medicare could be throwing away as much as $336 million worth of a costly Alzheimer's drug each year because the size of ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...

Current vial sizes may result in 5.8% of the Alzheimer's disease drug being thrown away, representing $1,619 in wasted ...

Potomac-based IGC Pharma Inc. Thursday announced enrollment of patients at the Baycrest Academy for Research and Education in ...

Alzheimer's is a brain disease that causes memory loss and thinking problems. It gets worse over time and is the most common ...

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...

A groundbreaking study has unveiled a potential game-changer in the fight against Alzheimer's disease. Scientists have ...

Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...

Eli Lilly invests £279M in the UK to boost life sciences, while its Alzheimer's drug, donanemab, faces European regulatory ...

Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown ...